Biykem Bozkurt

Biykem Bozkurt, kalp yetmezliği alanında klinik ve çeviri araştırmalarına, ulusal ve uluslararası bilimsel oturumlara aktif olarak katılım gösteren; tıp öğrencilerine ve asistanlara üniversite düzeyinde eğitim veren Türk kardiyoloji profesörü.

Amerikan İç Hastalıkları Kurulu'ndan Kardiyovasküler Hastalıklar ve İleri Kalp Yetmezliği ve Kardiyak Transplantasyon sertifikalarına sahiptir. Amerika'daki Houston Baylor College of Medicine Kardiyoloji Bölümü'nde eğitim vermeye devam etmektedir. Kendisi 2018 yılında yayınlanan "Tıp Bilimine Yön Veren 100 Türk" adlı bir kitapta yer alan 15 kadın bilim insanından birisidir.

İstanbul doğumludur. İstanbul Robert Koleji ve İstanbul Üniversitesi Tıp Fakültesinden mezun olmuştur. Amerika'daki Baylor College of Medicine ‘de kardiyoloji uzmanlığını almış, University of Pittsburgh Medical Center’da kalp yetmezliği ve kalp nakli eğitimini tamamlamıştır.

Doktorasını da Baylor College of Medicine’dan alan Dr. Bozkurt, Baylor College of Medicine'deki Kardiyoloji Bölümü'nde profesör ve kıdemli fakülte dekanı olarak çalışmaya devam etmektedir ve aynı zamanda aynı üniversitenin Winters Kalp Yetmezliği Araştırma Merkezi ve Mary ve Gordon Cain Vakfı başkanlığını yürütmektedir.

Dr. Bozkurt, 15 yılı aşkın süredir Amerika Kalp Yetmezliği Derneği (HFSA) üyesi ve en son başkanıdır. Birçok komitede görev yapmıştır; HFSA'nın stratejik planlama, savunuculuk, üyelik, bilimsel, araştırma ve eğitim faaliyetlerine katılmıştır.

Kendisi “Circulation” dergisinde kıdemli yardımcı editörlük yapmaktadır ve “American College of Cardiology Journal of Heart Failure Section” Editörlerinden biridir. Amerikan Kardiyoloji Koleji'nde en son Kalp Yetmezliği Konseyi Başkanı, AHA / ACC Kalp Yetmezliği Yönergeleri Yazma Komitesi üyeliği, ACC / AHA Klinik Veri Standartları Görev Gücü Başkanlığı, Amerika Kalp Yetmezliği Derneği Haznedarı ve Amerika Kalp Yetmezliği Derneği İcra Kurulu üyeliği görevlerini yapmış olup en son ACC/AHA Kalp Yetmezliği Yönergesi eş başkanlığını ve ACC/AHA Performans Önlemleri Komitesi eş başkanlığını yapmaktadır.

1: Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, Drazner MH, Filippatos GS, Fonarow GC, Givertz MM, Hollenberg SM, Lindenfeld J, Masoudi FA, McBride PE, Peterson PN, Stevenson LW, Westlake C. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017 Aug 8;136(6):e137-e161.  Epub 2017 Apr 28. PMID 28455343.

2: Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013 Oct 15;128(16):e240-327. doi: 10.1161/CIR.0b013e31829e8776. Epub 2013 Jun 5. PMID 23741058.

3: Bozkurt B, Aguilar D, Deswal A, Dunbar SB, Francis GS, Horwich T, Jessup M, Kosiborod M, Pritchett AM, Ramasubbu K, Rosendorff C, Yancy C; American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular and Stroke Nursing; Council on Hypertension; and Council on Quality and Outcomes Research. Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2016 Dec 6;134(23):e535-e578. doi:10.1161/CIR.0000000000000450. Epub 2016 Oct 31. PMID 27799274.

4: Bozkurt B, Colvin M, Cook J, Cooper LT, Deswal A, Fonarow GC, Francis GS, Lenihan D, Lewis EF, McNamara DM, Pahl E, Vasan RS, Ramasubbu K, Rasmusson K, Towbin JA, Yancy C; American Heart Association Committee on Heart Failure and Transplantation of the Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Epidemiology and Prevention; and Council on Quality of Care and Outcomes Research. Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association. Circulation. 2016 Dec 6;134(23):e579-e646. doi: 10.1161/CIR.0000000000000455.

5: Guglin M, Zucker MJ, Borlaug BA, Breen E, Cleveland J, Johnson MR, Panjrath GS, Patel JK, Starling RC, Bozkurt B; ACC Heart Failure and Transplant Member Section and Leadership Council. Evaluation for Heart Transplantation and LVAD Implantation: JACC Council Perspectives. J Am Coll Cardiol. 2020 Mar 31;75(12):1471-1487. doi: 10.1016/j.jacc.2020.01.034. PMID 32216916.

6: Bozkurt B, Coats AJS, Tsutsui H, Abdelhamid M,Adamopoulos S, Albert N, Anker SD, Atherton J, Böhm M, Butler J, Drazner MH, Felker GM, Filippatos G, Fiuzat M, Fonarow GC, Gomez-Mesa JE, Heidenreich P, Imamura T, Jankowska EA, Januzzi J, Khazanie P, Kinugawa K, Lam CSP, Matsue Y, Metra M, Ohtani T, Piepoli MF, Ponikowski P, Rosano GMC, Sakata Y, Seferović P, Starling RC, Teerlink JR, Vardeny O, Yamamoto K, Yancy C, Zhang J, Zieroth S. Universal definition and classification of heart failure: A report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by Canadian Heart Failure Society, Heart Failure Association of India, the Cardiac Society of Australia and New Zealand, and the Chinese Heart Failure Association. Eur J Heart Fail. 2021 Feb 19. doi: 10.1002/ejhf.2115. Epub ahead of print. PMID 33605000.

9: Bozkurt B, Villaneuva FS, Holubkov R, Tokarczyk T, Alvarez RJ Jr, MacGowan GA, Murali S, Rosenblum WD, Feldman AM, McNamara DM. Intravenous immune globulin in the therapy of peripartum cardiomyopathy. J Am Coll Cardiol. 1999 Jul;34(1):177-80. doi: 10.1016/s0735-1097(99)00161-8. PMID 10400008.

10: Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB, Gibbons R, Greenland P, Lackland DT, Levy D, O'Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith SC Jr, Sorlie P, Stone NJ, Wilson PW, Jordan HS, Nevo L, Wnek J,Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D,Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr,Tomaselli GF; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Jun 24;129(25 Suppl 2):S49-73. doi: 10.1161/01.cir.0000437741.48606.98. Epub 2013 Nov 12.

11: Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH,Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST,Smith SC Jr, Watson K, Wilson PW, Eddleman KM, Jarrett NM, LaBresh K, Nevo L,Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH,DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK,Smith SC Jr, Tomaselli GF; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Jun 24;129(25 Suppl 2):S1-45. doi: 10.1161/01.cir.0000437738.63853.7a. Epub 2013 Nov 12.

12: Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Guyton RA, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013 Apr 2;127(13):1425-43. doi: 10.1161/CIR.0b013e31828b82aa. Epub 2013 Mar 1. PMID 23457117.

13: Bozkurt B, Torre-Amione G, Warren MS, Whitmore J, Soran OZ, Feldman AM, Mann DL. Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure. Circulation. 2001 Feb 27;103(8):1044-7. doi: 10.1161/01.cir.103.8.1044. PMID 11222463.

14: Bozkurt B, Kribbs SB, Clubb FJ Jr, Michael LH, Didenko VV, Hornsby PJ, Seta Y, Oral H, Spinale FG, Mann DL. Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. Circulation. 1998 Apr 14;97(14):1382-91. doi: 10.1161/01.cir.97.14.1382. PMID 9577950.